Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency

Updated on: March 30,2024

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency

Updated on:March 30,2024

Researchers 3-D bio-print a model that could lead to improved anticancer drugs and treatments

by University of MinnesotaElectron microscopic image of a single human lymphocyte. Credit: Dr. Triche National Cancer InstituteUniversity of Minnesota researchers have developed a way to study ca

Updated on: June 28,2024

Researchers 3-D bio-print a model that could lead to improved anticancer drugs and treatments

by University of MinnesotaElectron microscopic image of a single human lymphocyte. Credit: Dr. Triche National Cancer InstituteUniversity of Minnesota researchers have developed a way to study ca

Updated on:June 28,2024

Study shows novel agent can overcome immune dysfunction in cancer

by Roswell Park Comprehensive Cancer CenterVSSP restores myeloid cell frequencies following leukopenia. C57BL/6 mice were injected with CY (200 mg/kg body weight, i.p.) and with two consecutive daily

Updated on: January 22,2024

Study shows novel agent can overcome immune dysfunction in cancer

by Roswell Park Comprehensive Cancer CenterVSSP restores myeloid cell frequencies following leukopenia. C57BL/6 mice were injected with CY (200 mg/kg body weight, i.p.) and with two consecutive daily

Updated on:January 22,2024

Research identifies a new drug candidate to starve and suffocate breast cancer cell stem growth

by University of SalfordMichael P. Lisanti. Credit: University of SalfordScientists have identified a new drug candidate that is able starve and suffocate cancer stem cells, paving the way for ne

Updated on: June 28,2024

Research identifies a new drug candidate to starve and suffocate breast cancer cell stem growth

by University of SalfordMichael P. Lisanti. Credit: University of SalfordScientists have identified a new drug candidate that is able starve and suffocate cancer stem cells, paving the way for ne

Updated on:June 28,2024

A new drug target for triple-negative breast cancer

by Louisiana State UniversityCredit: Louisiana State UniversityResearch led by Dr. Suresh Alahari, Professor of Biochemistry at LSU Health New Orleans' Schools of Medicine and Graduate Studie

Updated on: February 23,2024

A new drug target for triple-negative breast cancer

by Louisiana State UniversityCredit: Louisiana State UniversityResearch led by Dr. Suresh Alahari, Professor of Biochemistry at LSU Health New Orleans' Schools of Medicine and Graduate Studie

Updated on:February 23,2024

Study: Immunotherapy costs drive increase in Medicare spending for outpatient cancer care at the end of life

by American Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainA new study finds that recent increases in Medicare spending on outpatient cancer care at the end of patients' lives

Updated on: February 18,2024

Study: Immunotherapy costs drive increase in Medicare spending for outpatient cancer care at the end of life

by American Society for Radiation OncologyCredit: Pixabay/CC0 Public DomainA new study finds that recent increases in Medicare spending on outpatient cancer care at the end of patients' lives

Updated on:February 18,2024

Scientists develop a new model for glioblastoma using gene-edited organoids

by Salk InstituteOrganoids reveal how a deadly brain cancer grows. From left to right, tumor cells labeled with red fluorescent marker tdTomato spread in a cerebral organoid over a time period of

Updated on: March 01,2024

Scientists develop a new model for glioblastoma using gene-edited organoids

by Salk InstituteOrganoids reveal how a deadly brain cancer grows. From left to right, tumor cells labeled with red fluorescent marker tdTomato spread in a cerebral organoid over a time period of

Updated on:March 01,2024

Technology holds personalised cancer vaccine breakthrough

by Kate Zischke,University of QueenslandThe attack of a tumour cell made by white blood cells of the patient (lymphocytes) generated by cancer vaccines. Credit: University of QueenslandUniversit

Updated on: March 06,2024

Technology holds personalised cancer vaccine breakthrough

by Kate Zischke,University of QueenslandThe attack of a tumour cell made by white blood cells of the patient (lymphocytes) generated by cancer vaccines. Credit: University of QueenslandUniversit

Updated on:March 06,2024

Cellular origins of pediatric brain tumors identified

by McGill UniversityCredit: CC0 Public DomainA research team led by Dr. Claudia Kleinman, an investigator at the Lady Davis Institute at the Jewish General Hospital, together with Dr. Nada Jabado

Updated on: March 12,2024

Cellular origins of pediatric brain tumors identified

by McGill UniversityCredit: CC0 Public DomainA research team led by Dr. Claudia Kleinman, an investigator at the Lady Davis Institute at the Jewish General Hospital, together with Dr. Nada Jabado

Updated on:March 12,2024

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Updated on: March 30,2024

Second primary malignancies represent small proportion of adverse events after CAR T-cell therapy

by Elana GotkineSecond primary malignancies (SPMs) represent a small proportion of adverse events (AEs) reported by patients receiving chimeric antigen receptor T-cell (CAR T-cell) therapy, according

Updated on:March 30,2024

Using algorithms to track down cancer

by Andres Eberhard ,ETH ZurichCEO Peter Nestorov's (2nd from right) company now employs over 20 people (Photograph: ETH Zurich / Scailyte).Modern medicine is looking for markers that p

Updated on: May 11,2024

Using algorithms to track down cancer

by Andres Eberhard ,ETH ZurichCEO Peter Nestorov's (2nd from right) company now employs over 20 people (Photograph: ETH Zurich / Scailyte).Modern medicine is looking for markers that p

Updated on:May 11,2024

Study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

by Anne Doerr,Yale UniversityCredit: stock.adobe.comThe checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a

Updated on: May 31,2024

Study shows checkpoint inhibitor prolongs survival in patients with certain head and neck cancers

by Anne Doerr,Yale UniversityCredit: stock.adobe.comThe checkpoint inhibitor pembrolizumab (Keytruda) increases the survival time of patients with advanced head and neck cancers, according to a

Updated on:May 31,2024